Mucosal Reason 4 O O
surfaces Reason 4 O O
are Reason 4 O O
among Reason 4 O O
the Reason 4 O O
primary Reason 4 O O
and Reason 4 O O
most Reason 4 O O
vulnerable Reason 4 O O
areas Reason 4 O O
of Reason 4 O O
our Reason 4 O O
body Reason 4 O O
when Reason 4 O O
it Reason 4 O O
comes Reason 4 O O
to Reason 4 O O
viral Reason 4 O O
entry Reason 4 O O
and Reason 4 O O
infection. Reason 4 O O
The Reason 4 O O
Iwasaki Reason 4 O O
Lab Reason 4 O O
hopes Reason 4 O O
to Reason 4 O O
present Reason 4 O O
new Reason 4 O O
ways Reason 4 O O
to Reason 4 O O
administer Reason 4 O O
vaccines Reason 4 O O
that Reason 4 O O
confer Reason 4 O O
certain Reason 4 O O
protective Reason 4 O O
advantages Reason 4 O O
over Reason 4 O O
conventional Reason 4 O O
methods. Reason 4 O O
Below Reason 4 O O
are Reason 4 O O
two Reason 4 O O
such Reason 4 O O
mechanisms, Reason 4 O O
studied Reason 4 O O
in Reason 4 O O
the Reason 4 O O
context Reason 4 O O
of Reason 4 O O
the Reason 4 O O
herpes Reason 4 O O
virus Reason 4 O O
and Reason 4 O O
COVID-19 Reason 4 O O
virus, Reason 4 O O
respectively. Reason 4 O O
We Reason 4 O O
are Reason 4 O O
currently Reason 4 O O
developing Reason 4 O O
other Reason 4 O O
innovative Reason 4 O O
vaccine Reason 4 O O
approaches. Reason 4 O O
Prime O O O O
and O O O O
Pull: O O O O
Effective O O O O
recruitment O O O O
of O O O O
immune O O O O
cells O O O O
to O O O O
sites O O O O
of O O O O
viral O O O O
infection O O O O
is O O O O
critical O O O O
for O O O O
treatment O O O O
and O O O O
recovery O O O O
from O O O O
various O O O O
diseases, O O O O
but O O O O
our O O O O
body's O O O O
natural O O O O
response O O O O
in O O O O
doing O O O O
so O O O O
can O O O O
be O O O O
compromised O O O O
for O O O O
a O O O O
number O O O O
of O O O O
reasons. O O O O
Organs O O O O
such O O O O
as O O O O
the O O O O
intestines O O O O
and O O O O
lung O O O O
airways O O O O
— O O O O
as O O O O
well O O O O
as O O O O
the O O O O
human O O O O
vaginal O O O O
tract, O O O O
for O O O O
instance, O O O O
often O O O O
restrict O O O O
T-cell O O O O
entry O O O O
unless O O O O
in O O O O
the O O O O
case O O O O
of O O O O
inflammation. O O O O
Understanding O O O O
that O O O O
many O O O O
current O O O O
therapeutics O O O O
have O O O O
difficulty O O O O
circumventing O O O O
this O O O O
barrier, O O O O
the O O O O
Iwasaki O O O O
Lab O O O O
has O O O O
helped O O O O
develop O O O O
a O O O O
mechanism O O O O
called O O O O
["prime O O O O
and O O O O
pull,"](https://www.nature.com/articles/s41541-019-0129-1) O O O O
which O O O O
has O O O O
shown O O O O
significant O O O O
promise O O O O
in O O O O
both O O O O
reducing O O O O
the O O O O
spread O O O O
of O O O O
infection O O O O
and O O O O
preventing O O O O
recurrent O O O O
symptoms O O O O
caused O O O O
by O O O O
mucosal O O O O
viruses. O O O O
There Reason 4 O O
are Reason 4 O O
two Reason 4 O O
main Reason 4 O O
steps Reason 4 O O
to Reason 4 O O
the Reason 4 O O
method: Reason 4 O O
first, Reason 4 O O
a Reason 4 O O
conventional Reason 4 O O
intramuscular Reason 4 O O
vaccination Reason 4 O O
is Reason 4 O O
administered Reason 4 O O
to Reason 4 O O
"prime" Reason 4 O O
and Reason 4 O O
initiate Reason 4 O O
systemic Reason 4 O O
T-cell Reason 4 O O
response. Reason 4 O O
Next, Reason 4 O O
a Reason 4 O O
cream Reason 4 O O
containing Reason 4 O O
medication Reason 4 O O
that Reason 4 O O
"pulls" Reason 4 O O
T-cells Reason 4 O O
to Reason 4 O O
the Reason 4 O O
site Reason 4 O O
of Reason 4 O O
viral Reason 4 O O
growth Reason 4 O O
is Reason 4 O O
applied Reason 4 O O
on Reason 4 O O
or Reason 4 O O
under Reason 4 O O
the Reason 4 O O
skin; Reason 4 O O
this Reason 4 O O
establishes Reason 4 O O
an Reason 4 O O
existing Reason 4 O O
pool Reason 4 O O
of Reason 4 O O
protective Reason 4 O O
memory Reason 4 O O
T-cells Reason 4 O O
within Reason 4 O O
peripheral Reason 4 O O
tissue Reason 4 O O
where Reason 4 O O
T-cell Reason 4 O O
travel Reason 4 O O
and Reason 4 O O
entry Reason 4 O O
might Reason 4 O O
naturally Reason 4 O O
be Reason 4 O O
restricted. Reason 4 O O
Prior Reason 4 O O
research Reason 4 O O
has Reason 4 O O
demonstrated Reason 4 O O
that Reason 4 O O
tissue-resident Reason 4 O O
memory Reason 4 O O
T-cells Reason 4 O O
are Reason 4 O O
much Reason 4 O O
more Reason 4 O O
efficacious Reason 4 O O
than Reason 4 O O
circulating Reason 4 O O
memory Reason 4 O O
T-cells, Reason 4 O O
partially Reason 4 O O
because Reason 4 O O
of Reason 4 O O
their Reason 4 O O
locality. Reason 4 O O
The O O O O
Iwasaki O O O O
Lab O O O O
tested O O O O
the O O O O
"prime O O O O
and O O O O
pull" O O O O
method O O O O
on O O O O
[guinea O O O O
pigs](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671986/) O O O O
already O O O O
infected O O O O
with O O O O
the O O O O
herpes O O O O
simplex O O O O
virus O O O O
to O O O O
examine O O O O
its O O O O
efficacy O O O O
in O O O O
preventing O O O O
recurrent O O O O
herpes O O O O
lesions. O O O O
In Reason 5 O O
one Reason 5 O O
group, Reason 5 O O
individuals Reason 5 O O
were Reason 5 O O
given Reason 5 O O
both Reason 5 O O
a Reason 5 O O
traditional Reason 5 O O
vaccine Reason 5 O O
and Reason 5 O O
a Reason 5 O O
cream Reason 5 O O
that Reason 5 O O
had Reason 5 O O
imiquimod, Reason 5 O O
a Reason 5 O O
substance Reason 5 O O
commonly Reason 5 O O
used Reason 5 O O
to Reason 5 O O
treat Reason 5 O O
skin Reason 5 O O
tumors, Reason 5 O O
warts, Reason 5 O O
and Reason 5 O O
which Reason 5 O O
increases Reason 5 O O
the Reason 5 O O
activity Reason 5 O O
of Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
system. Reason 5 O O
The Reason 5 O O
results Reason 5 O O
supported Reason 5 O O
the Reason 5 O O
team's Reason 5 O O
hypotheses: Reason 5 O O
a Reason 5 O O
combination Reason 5 O O
of Reason 5 O O
priming Reason 5 O O
and Reason 5 O O
pulling Reason 5 O O
exceeded Reason 5 O O
the Reason 5 O O
efficiency Reason 5 O O
of Reason 5 O O
the Reason 5 O O
vaccine Reason 5 O O
or Reason 5 O O
cream Reason 5 O O
alone, Reason 5 O O
reducing Reason 5 O O
the Reason 5 O O
ability Reason 5 O O
of Reason 5 O O
the Reason 5 O O
HSV-2 Reason 5 O O
to Reason 5 O O
reactivate Reason 5 O O
from Reason 5 O O
latency Reason 5 O O
in Reason 5 O O
sensory Reason 5 O O
neurons. Reason 5 O O
But Reason 5 O O
the Reason 5 O O
good Reason 5 O O
news Reason 5 O O
didn't Reason 5 O O
just Reason 5 O O
end Reason 5 O O
there. Reason 5 O O
Priming Reason 5 O O
and Reason 5 O O
pulling Reason 5 O O
also Reason 5 O O
blocked Reason 5 O O
blisters Reason 5 O O
from Reason 5 O O
forming Reason 5 O O
when Reason 5 O O
administered Reason 5 O O
to Reason 5 O O
guinea Reason 5 O O
pigs Reason 5 O O
with Reason 5 O O
recurrent Reason 5 O O
herpes Reason 5 O O
disease Reason 5 O O
— Reason 5 O O
suggesting Reason 5 O O
a Reason 5 O O
potential Reason 5 O O
solution Reason 5 O O
to Reason 5 O O
controlling Reason 5 O O
disease Reason 5 O O
course Reason 5 O O
in Reason 5 O O
an Reason 5 O O
individual. Reason 5 O O
Researchers Reason 5 O O
in Reason 5 O O
the Reason 5 O O
lab Reason 5 O O
are Reason 5 O O
hopeful Reason 5 O O
that Reason 5 O O
the Reason 5 O O
new Reason 5 O O
mechanism Reason 5 O O
will Reason 5 O O
chart Reason 5 O O
future Reason 5 O O
development Reason 5 O O
in Reason 5 O O
the Reason 5 O O
fight Reason 5 O O
against Reason 5 O O
mucosal Reason 5 O O
viral Reason 5 O O
diseases, Reason 5 O O
and Reason 5 O O
look Reason 5 O O
forward Reason 5 O O
to Reason 5 O O
conversations Reason 5 O O
with Reason 5 O O
biotechnology Reason 5 O O
and Reason 5 O O
pharma Reason 5 O O
companies Reason 5 O O
on Reason 5 O O
taking Reason 5 O O
advantage Reason 5 O O
of Reason 5 O O
this Reason 5 O O
combination Reason 5 O O
vaccine Reason 5 O O
strategy Reason 5 O O
to Reason 5 O O
improve Reason 5 O O
outcomes Reason 5 O O
for Reason 5 O O
patients. Reason 5 O O
Prime O O O O
and O O O O
Spike: O O O O
The O O O O
COVID-19 O O O O
pandemic O O O O
has O O O O
sent O O O O
medical O O O O
communities O O O O
around O O O O
the O O O O
world O O O O
into O O O O
an O O O O
arms O O O O
race O O O O
of O O O O
vaccine O O O O
development; O O O O
dose O O O O
after O O O O
dose O O O O
and O O O O
booster O O O O
after O O O O
another, O O O O
our O O O O
research O O O O
co-evolves O O O O
with O O O O
the O O O O
virus, O O O O
which O O O O
persistently O O O O
adapts O O O O
to O O O O
become O O O O
transmissible. O O O O
The Reason 4 O O
Iwasaki Reason 4 O O
lab Reason 4 O O
[presents](https://medicine.yale.edu/news-article/nasal-approach-to-covid-vaccination-gains-traction-at-yale/) Reason 4 O O
a Reason 4 O O
new Reason 4 O O
mechanism Reason 4 O O
of Reason 4 O O
administering Reason 4 O O
booster Reason 4 O O
shots Reason 4 O O
that Reason 4 O O
might Reason 4 O O
turn Reason 4 O O
tables Reason 4 O O
in Reason 4 O O
our Reason 4 O O
struggle Reason 4 O O
against Reason 4 O O
this Reason 4 O O
global Reason 4 O O
pandemic: Reason 4 O O
priming Reason 4 O O
and Reason 4 O O
spiking. Reason 4 O O
After Reason 4 O O
receiving Reason 4 O O
traditional Reason 4 O O
mRNA-based Reason 4 O O
vaccines, Reason 4 O O
patients Reason 4 O O
would Reason 4 O O
receive Reason 4 O O
reinforcement Reason 4 O O
delivered Reason 4 O O
directly Reason 4 O O
to Reason 4 O O
their Reason 4 O O
nose, Reason 4 O O
which Reason 4 O O
contains Reason 4 O O
and Reason 4 O O
leads Reason 4 O O
to Reason 4 O O
the Reason 4 O O
parts Reason 4 O O
of Reason 4 O O
the Reason 4 O O
body Reason 4 O O
most Reason 4 O O
affected Reason 4 O O
by Reason 4 O O
viral Reason 4 O O
infection. Reason 4 O O
The Reason 4 O O
second Reason 4 O O
step Reason 4 O O
would Reason 4 O O
come Reason 4 O O
in Reason 4 O O
the Reason 4 O O
form Reason 4 O O
of Reason 4 O O
a Reason 4 O O
spray Reason 4 O O
containing Reason 4 O O
coronavirus-derived Reason 4 O O
spike Reason 4 O O
proteins Reason 4 O O
— Reason 4 O O
and Reason 4 O O
in Reason 4 O O
some Reason 4 O O
cases, Reason 4 O O
a Reason 4 O O
non-inflammable Reason 4 O O
and Reason 4 O O
biodegradable Reason 4 O O
polymer Reason 4 O O
coat. Reason 4 O O
Conventional Reason 4 O O
intramuscular Reason 4 O O
boosters, Reason 4 O O
the Reason 4 O O
type Reason 4 O O
most Reason 4 O O
popular Reason 4 O O
today, Reason 4 O O
unfortunately Reason 4 O O
show Reason 4 O O
diminished Reason 4 O O
ability Reason 4 O O
to Reason 4 O O
fight Reason 4 O O
the Reason 4 O O
virus Reason 4 O O
over Reason 4 O O
time Reason 4 O O
— Reason 4 O O
and Reason 4 O O
also Reason 4 O O
lack Reason 4 O O
efficiency Reason 4 O O
in Reason 4 O O
the Reason 4 O O
mucosa Reason 4 O O
of Reason 4 O O
the Reason 4 O O
vulnerable Reason 4 O O
nasal Reason 4 O O
cavity Reason 4 O O
and Reason 4 O O
respiratory Reason 4 O O
tract. Reason 4 O O
On Reason 4 O O
the Reason 4 O O
other Reason 4 O O
hand, Reason 4 O O
the Reason 4 O O
prime Reason 4 O O
and Reason 4 O O
spike Reason 4 O O
mechanism Reason 4 O O
induces Reason 4 O O
a Reason 4 O O
robust Reason 4 O O
population Reason 4 O O
of Reason 4 O O
tissue-resident Reason 4 O O
memory Reason 4 O O
T-cells, Reason 4 O O
B-cells, Reason 4 O O
and Reason 4 O O
immunoglobulin Reason 4 O O
A Reason 4 O O
directly Reason 4 O O
in Reason 4 O O
the Reason 4 O O
respiratory Reason 4 O O
mucosa, Reason 4 O O
strengthening Reason 4 O O
the Reason 4 O O
body's Reason 4 O O
systemic Reason 4 O O
prevention Reason 4 O O
of Reason 4 O O
viral Reason 4 O O
entry Reason 4 O O
and Reason 4 O O
offering Reason 4 O O
cross-reactive, Reason 4 O O
cross-protective Reason 4 O O
immunity. Reason 4 O O
Researchers O O O O
at O O O O
the O O O O
Iwasaki O O O O
Lab O O O O
developed O O O O
this O O O O
method O O O O
after O O O O
drawing O O O O
inspiration O O O O
from O O O O
their O O O O
work O O O O
with O O O O
the O O O O
influenza O O O O
virus. O O O O
For O O O O
both O O O O
illnesses, O O O O
infected O O O O
individuals O O O O
who O O O O
received O O O O
priming O O O O
and O O O O
pulling O O O O
had O O O O
less O O O O
viral O O O O
load O O O O
in O O O O
their O O O O
nasal O O O O
cavity O O O O
and O O O O
lungs, O O O O
affirming O O O O
the O O O O
reduced O O O O
viral O O O O
infection O O O O
and O O O O
transmission O O O O
made O O O O
possible O O O O
by O O O O
the O O O O
treatment. O O O O
Prime O O O O
and O O O O
Spike O O O O
technology O O O O
forms O O O O
the O O O O
scientific O O O O
